&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-10-24, 21:00

Acronis Achieves Remarkable Expansion in Mexico with Significant 53% Revenue Growth
Clarita Gooden

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-10-17, 20:08

Bipsync and Dasseti Partner to Streamline Research and Due Diligence Processes for Investment Management
Clarita Gooden

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-10-09, 14:55

FLYR and Riyadh Air Partner to Deliver the World’s First Digitally-Native Airline, Utilizing Offer and Order Technology
Clarita Gooden

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-10-02, 22:01

Curium Công bố Quan hệ Đối tác Chiến lược với PeptiDream nhằm phát triển Đồng vị phóng xạ trong Chuẩn trị ung thư tuyến tiền liệt tại Nhật Bản
Clarita Gooden

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-09-26, 00:02

REVO ZERO and Grupo Édora join forces to accelerate the green hydrogen revolution
Clarita Gooden

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-09-19, 14:00

Argentina’s BYMA to Adopt Nasdaq’s Clearing Platform
Clarita Gooden

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-09-05, 21:52

Boehringer Ingelheim announces plans to advance potential new treatment for Geographic Atrophy, following positive Phase I results
Clarita Gooden

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-08-27, 10:00

David Barrett, CEO of EBC Financial Group (UK) Ltd and EBC Financial Group (Cayman) Limited, Analyses Global Market Volatility, High-Interest Rate Pressures, and Safe-Haven Investment Strategies Amid 2024 Economic Shifts
Clarita Gooden

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-08-02, 15:22

Belgium Ignites Global Debate by Changing Gambling Age, Highlighting Huge Regulatory Gaps
Clarita Gooden

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-06-20, 21:46

Rapafusyn Pharmaceuticals Secures $28 Million Series A to Advance Its Non-Degrading Molecular Glue Drug Discovery Platform
Clarita Gooden

Popular Posts